Reports/TTMI
TTMI

TTMI - TTM Technologies Inc

OPPORTUNISTIC BUYIN BUY ZONETechnology - Hardware, Equipment & PartsAnalysis generated 2026-10-04Market data as of 2026-11-12Market data 3 days oldUSD 76.28
56
Conviction
out of 100

Executive Summary

TTM Technologies Inc (TTMI) is a US-headquartered manufacturer of printed circuit boards (PCBs), radio-frequency (RF) components and engineered substrates serving aerospace and defence, networking/communications, automotive, and industrial end-markets. The company operates a global manufacturing footprint across North America and Asia and is positioned as one of the larger independent PCB suppliers in the Western world, with particular depth in defence-grade and high-mix low-volume production. The current share price of USD131.87 sits roughly 41% below the 52-week high of USD223.83 and approximately 147% above the 52-week low of USD53.80, reflecting a sharp de-rating from earlier 2026 levels.

The investment case rests on continued defence programme momentum (anchored by a named Raytheon contract), the ongoing integration of recently completed acquisitions, and a management 2026 sales growth target of 15 - 20% over 2025. The key near-term catalyst is the Q2 2026 earnings release, scheduled for the period following the 29 April 2026 guidance update, where execution against the USD930m - USD970m revenue range and updated capital expenditure of USD300m - USD320m will be the focus. The primary risk is that geopolitical instability or macro volatility disclosed in the 10-K delays customer orders or compresses margins, undermining the growth trajectory already priced into the shares.

Bottom line: OPPORTUNISTIC BUY. Conviction Score: 56/100. The view would be upgraded on a clean Q2 print at the top of guidance with no margin disappointment, and downgraded on a miss to the revenue band or a material defence contract slippage.

Buy zone. Current price USD 76.28 is at or below the buy ceiling of USD 108.33. New positions are justified by the model.
IN BUY ZONEOPPORTUNISTIC BUY · 56/100Now USD 76.28 · buy ≤ USD 108.33 · trim ≥ USD 155.00

Thesis break: Loss or material descoping of the named Raytheon defence contract, full-year 2026 revenue tracking below the 15 - 20% growth guidance, or a dilutive acquisition financing event that breaks the integration story.

Business Model

TTM Technologies generates revenue primarily through the design, manufacture and sale of printed circuit boards, backplanes, RF/microwave components, and engineered substrates, with the majority of demand historically tied to aerospace and defence programmes, followed by networking and communications infrastructure, automotive electronics (including EV and ADAS applications), and industrial customers. Products range from quick-turn, high-mix low-volume builds for prototype customers to high-volume production runs at larger Asian facilities, allowing TTM to capture work across the product lifecycle. Customers include defence primes, commercial aerospace integrators, network equipment original equipment manufacturers (OEMs), and Tier 1 automotive suppliers; the company has highlighted Raytheon as a named defence customer and has flagged commercial ramp programmes that can transition customers to volume facilities in China or Malaysia.

Reported gross margin dynamics have been supported by a richer mix of defence and aerospace work and by the absorption of fixed costs across the manufacturing base, although margins remain sensitive to utilisation, raw material costs (notably copper and laminates), and FX. Capital intensity is meaningful - the company has raised its 2026 capital expenditure guidance to USD300m - USD320m, consistent with capacity additions in higher-value substrates and RF work. The competitive moat, where it exists, derives from facility-level specialisation (a stated strategy in the 10-K), long-cycle defence qualifications, US-based capacity for ITAR- and security-sensitive programmes work, and incumbency on long-lived aerospace platforms; however, the industry remains fragmented and price-competitive in commercial segments, so differentiation is concentrated in defence and high-mix engineering rather than across the full portfolio.

Financial Snapshot

Price
USD 76.28
Market Cap
USD 13.9bn
P/E Ratio
59.5x
52w High
USD 223.83
52w Low
USD 53.36
Distance from 52wH
-65.9%
Beta
2.14
Avg Volume
1990644
Currency
USD

Recent Catalysts

[29 April 2026] - TTM Technologies provided Q2 2026 earnings guidance, projecting revenue of USD930m - USD970m and raising 2026 capital expenditure guidance to USD300m - USD320m, alongside full-year net sales growth of 15 - 20% over 2025. Source: TTM Technologies press release (via Seeking Alpha and MarketScreener).

[7 May 2026] - TTM Technologies announced board refresh and governance changes. Source: TipRanks (company announcement).

[27 May 2026] - TTM Technologies hosted its 2026 Investor Day, with management discussing business outlook and future opportunities across PCBs and substrates. Source: TTM Technologies press release (StockTitan and company IR site).

[5 August 2026] - TTM Technologies submitted a Form 8-K current event report to disclose a corporate event. Source: SEC EDGAR 8-K filing (6 August 2026).

Thesis Evaluation

Bull Case (23% weight)

Defence backlog conversion accelerates on the named Raytheon programme, acquisitions deliver ahead-of-plan synergies, and the higher 2026 capex envelope (USD300m - USD320m) translates into margin expansion in 2027 as new substrate and RF capacity ramps. On this path, multiple compression is offset by earnings upgrades, supporting a 12-month price target of USD195.

Base Case (49% weight)

TTM delivers against its Q2 2026 revenue range of USD930m - USD970m, posts full-year sales growth of 15 - 20% over 2025 in line with guidance, and completes the integration of recent acquisitions without major margin disruption. Defensive programme momentum offsets any softness in commercial networking, and the shares re-rate modestly from current levels to a 12-month price target of USD155.

Bear Case (28% weight)

Geopolitical instability or programme delays disclosed as risk factors in the 10-K push out customer orders, capex absorption weighs on margins, and the elevated starting valuation (the research data flags a roughly 59.5x P/E) compresses sharply on any execution shortfall. In that scenario, the shares derate to a 12-month price target of USD85.

Weighted conviction:Bull (23%) x 100 + Base (49%) x 62 + Bear (28%) x 10 = 56/100. OPPORTUNISTIC BUY.

Key Risks

  1. Geopolitical and macro volatility: The 10-K flags exposure to global economic volatility and geopolitical instability that could delay customer orders, particularly in defence export markets. Estimated probability: 35%. Impact: severe.
  2. Valuation risk on execution shortfall: Research notes flag a starting P/E around 59.5x, leaving limited room for any revenue or margin disappointment relative to the 15 - 20% growth and Q2 USD930m - USD970m guidance. Estimated probability: 30%. Impact: severe.
  3. Customer concentration on defence programmes: Heavy reliance on a small number of defence primes - including the named Raytheon contract - means any programme cancellation, protest, or funding delay would have an outsized impact on backlog conversion. Estimated probability: 20%. Impact: severe.
  4. Integration risk from completed acquisitions: Recently completed acquisitions add capability but also execution risk; synergy slippage or integration costs could compress margins and distract management from organic delivery. Estimated probability: 30%. Impact: moderate.
  5. Capex absorption and return on investment: The raised 2026 capital expenditure range of USD300m - USD320m increases depreciation and requires disciplined utilisation; under-utilised new capacity would weigh on returns. Estimated probability: 25%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Long-only investors with a minimum 12 - 18 month holding horizon, a moderate-to-high risk tolerance, and a thesis that US-aligned PCB capacity and defence backlog conversion can compound earnings. Suitability is highest for those who can tolerate valuation-driven drawdowns around earnings prints and who want exposure to defence electronics and engineered substrates rather than pure commercial cycle plays.

Avoid if: Investors with a short trading horizon (under six months), a low tolerance for valuation volatility, or mandates that exclude defence exposure or hardware/equipment names. Conservative income-oriented investors, those unable to underwrite the named customer-concentration risk, or anyone whose process requires a meaningful dividend yield should also look elsewhere.

Recommendation

OPPORTUNISTIC BUY - 56/100. The tier reflects a setup where concrete defence contract momentum, completed acquisitions, and explicit 2026 sales growth guidance of 15 - 20% justify incremental exposure, but where an elevated starting valuation and filing-disclosed geopolitical risk keep conviction at the lower end of a buy range. The call would be upgraded to a higher-conviction tier on a clean Q2 2026 print at or above the USD930m - USD970m revenue band with no margin disappointment, and would be downgraded on a guidance miss, a material defence programme slippage, or evidence that acquisition synergies are tracking below plan. At the current price of $76.28 the shares sit inside our buy zone (below $108.33): the risk/reward on the scenario set clears our 2:1 threshold today.

The probability-weighted value across our three scenarios is $144.60, 90% above the current price of $76.28 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $108.33 - below this level the upside to the base-case target ($155.00) is at least 2x the downside to the bear case ($85.00), the minimum risk/reward we require before committing new capital.

HOLD

between $108.33 and $155.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $155.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 23%.

SELL

if loss or material descoping of the named Raytheon defence contract, full-year 2026 revenue tracking below the 15 - 20% growth guidance, or a dilutive acquisition financing event that breaks the integration story, regardless of price - the bear target of $85.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 56/100. Trend versus prior report: Initiation.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-10-04
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-10-0456

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Company press releases distributed via Seeking Alpha, MarketScreener and StockTitan, public news flow covering the Q2 2026 guidance update and 2026 capital expenditure revision, regulatory filings including the 10-K and current 8-K filed on 6 August 2026, the 27 May 2026 Investor Day materials, and analyst commentary covering the Q2 2026 earnings guidance update.

Primary source types: SEC filings (10-K Item 1A and Form 8-K with attached exhibit), company press releases and investor relations announcements, investor day disclosures, and third-party financial news wires reporting the company's public guidance.

Key sources

Analysis generated 2026-10-04. Market data as of 2026-11-12.

\n